PSX vs ZNTL · P/E 17, rev $83.54B vs $257.7M cap
Phillips 66 (PSX) versus Zentalis Pharmaceuticals Llc (ZNTL) — a side-by-side from cached financials, not a winner call.
Phillips 66 (PSX) is a oil & gas refining & marketing company listed on NYSE.
Zentalis Pharmaceuticals Llc (ZNTL) is a biotechnology company listed on NASDAQ.
Latest reported PSX revenue for 2026-06-30 was $83.54B. Net income was $4.05B. PSX currently screens at market cap $67.02B and trailing P/E 16.5.
Latest reported ZNTL revenue for 2025-09-30 was $0. Net income was -$26.7M. ZNTL currently screens at market cap $257.7M.
PSX currently screens at market cap $67.02B and trailing P/E 16.5. ZNTL currently screens at market cap $257.7M.
Not investment advice. Open the PSX and ZNTL stock pages for the full models.
Not investment advice.